NCT00984633View on ClinicalTrials.gov

Study of Efficacy, Pharmacokinetics, and Safety of Bolus Maintenance Doses of Org 9426 (Study P05976)(COMPLETED)

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

December 31, 2003

Study Completion Date

December 31, 2003

Conditions
Muscle Relaxation
Interventions
DRUG

Rocuronium bromide (Org 9426)

0.6 mg/kg injection intubation dose

DRUG

Rocuronium bromide (Org 9426)

0.9 mg/kg injection intubation dose

DRUG

Sevoflurane

0.5-2.0% intravenous maintenance anesthesia

DRUG

Propofol

4-10 mg/kg/hr maintenance anesthesia

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00984633 - Study of Efficacy, Pharmacokinetics, and Safety of Bolus Maintenance Doses of Org 9426 (Study P05976)(COMPLETED) | Biotech Hunter | Biotech Hunter